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Abstract
Complement factor H (CFH) is a central regulator of the complement system and has been implicated in the etiology of age-
related macular degeneration (AMD), a leading cause of blindness in the elderly. In view of previous studies showing that
reduced expression of CFH in the retina is a risk factor for developing AMD, there is significant interest in understanding
how CFH expression is regulated in the retina. In this study, we have shown that the anti-inflammatory cytokine, IL-27,
induced CFH expression in mouse retinal cells and human retinal pigmented epithelial cells (RPE) through STAT1-mediated
up-regulation of Interferon Regulatory Factor-1 (IRF-1) and IRF-8. We further show that cells in the ganglion and inner-
nuclear layers of the retina constitutively express IRF-1 and IRF-8 and enhanced CFH expression in the retina during ocular
inflammation correlated with significant increase in the expression of IRF-1, IRF-8 and IL-27 (IL-27p28 and Ebi3). Our data
thus reveal a novel role of IL-27 in regulating complement activation through up-regulation of CFH and suggest that defects
in IL-27 signaling or expression may contribute to the reduction of CFH expression in the retina of patients with AMD.
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Introduction
The vertebrate eye is comprised of highly specialized tissues of
the retina, cornea, lens, iris, ciliary body, choroid, sclera, aqueous
humor and vitreous body and its primary function is to receive and
convert incident light rays into visual images. To ensure the fidelity
of the visual image, the optical axis (cornea, anterior chamber, lens
and vitreous body) through which the light is transmitted, must be
transparent and devoid of lymphoreticular cells [1]. Intraocular
inflammation, characterized by influx of inflammatory cells into
the retina, is therefore highly undesirable because it compromises
the requisite transparency of the optical axis. Moreover, in-
flammatory mediators secreted by the inflammatory cells promote
undesirable angiogenesis, fibrosis and tissue destruction [1]. Thus,
ocular immunity is predicated on the paramount need to preserve
vision while neutralizing pathogenic stimuli with minimal collat-
eral damage to ocular structures. The complement system plays
a central role in conferring innate immunity against microbes in
the eye and it functions through sequential activation of cascades
of proteases and a cell-killing membrane attack complex that
generate cleavage fragments which amplify the inflammatory
response. The uncontrolled activation of the complement pathway
in the eye is therefore dangerous as it is potentially injurious to
terminally differentiated photoreceptors and neurons of the
neuroretina. This calamity is obviated by the production of
a family of complement control proteins of which complement
factor H (CFH) is a prominent member.
CFH is a multifunctional protein that acts as a central regulator
of the complement system [2]. It regulates the levels of newly
generated C3b molecules by serving as a cofactor for complement
factor I in degrading C3b [2] and destabilizing the alternative
complement C3 convertase, C3bBb (decay-accelerating activity).
CFH is one of several genes identified in genome-wide association
studies [3,4,5,6,7,8] to be implicated in age-related macular
degeneration (AMD), the leading cause of irreversible blindness in
the elderly [9,10,11]. Although the pathophysiology of AMD is not
well understood, recent reports suggest that defects in mechanisms
that control chronic inflammation or down-regulate complement
activation play crucial roles [9,10,11]. CFH variants that express
reduced amounts of CFH or have low complement-modulating
activity have been suggested as risk factors for developing AMD
[12].
CFH is constitutively expressed in the liver and the liver
produces the highest level of CFH in the body [2]. Significant
amounts of CFH are also produced in the eye, with the highest
levels detected in the retinal pigment epithelia (RPE), choroid and
the retina [13]. The pro-inflammatory cytokine, IFN-g has been
shown to up-regulate the expression of CFH in hepatocytes,
astrocytes, lung cells and astroglioma cell lines [14,15] and these
observations are consistent with the presence of two IFN-g
activation sites (GAS) within the CFH proximal promoter
[16,17,18]. With the knowledge that defects in CFH production
may contribute to the development of AMD, it is remarkable that
less is known about mechanisms involved in the regulation of CFH
production in the normal retina. The transcription factor, STAT1
(signal transducer and activator of transcription 1), has been shown
to activate the transcription of CFH in the human retinal pigment
epithelia (RPE) cell line, ARPE-19 following stimulation by IFN-g
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[12,19]. On the other hand, oxidative stress reduced the ability of
IFN-g to increase CFH expression in ARPE-19 by enhancing
FOXO3a binding to the CFH promoter and inhibiting interaction
of STAT1 with the CFH promoter [12,19]. These studies
established the central role of STAT1 in the regulation of CFH
in RPE. However, IFN-g is not present in the normal retina nor is
it secreted by retinal cells and could therefore not be responsible
for activating STAT1 required for constitutive expression of CFH
in the retina. We therefore posited that other cytokines such as IL-
27 or growth factors produced by retinal cells may be the source of
the activated STAT1 needed to induce transcription of the CFH
gene.
Interleukin-27 (IL-27) is an anti-inflammatory heterodimeric
cytokine comprised of IL-27p40 and EBI3 (Epstein-Barr virus
(EBV)-induced gene 3) subunits [20]. It is constitutively secreted by
retinal microglia and in a previous study we showed that IL-27
suppressed intraocular inflammation through activation of STAT1
[21,22]. In this study, we have investigated whether IL-27 can up-
regulate the expression of CFH in retinal cells. We show here that
IL-27 induces CFH expression in freshly isolated primary mouse
retinal cells and human retinal epithelial cells through activation of
STAT1 and up-regulation of the STAT1 target genes, Interferon
Regulatory Factor-1 (IRF-1) and IRF-8.
Methods
Mice
C57BL/6 mice (6–8 weeks old) were from Jackson Laboratory
(Bar Harbor, ME). STAT1-deficient mice were a gift from Dr D.
Levy New York University NY. We generated STAT3 conditional
deletion in the retina by breeding STAT3F/F mice with a-Cre
transgenic mice, which express Cre-recombinase only in the retina
(generously provided by Dr. Gruss) [23]. Generation and
characterization of transgenic mice with targeted over-expression
of SOCS1 in the retina (SOCS1-Tg) has previously been described
[24]. All mice were housed in clean animal rooms operated under
barrier conditions. Animal care and use was in compliance with
Association for Assessment and Accreditation of Laboratory
Animal Care, International (AAALAC) and the NIH Intramural
Animal Care & Use Program guidelines. This study was approved
by the National Eye Institute/NIH Animal Care and Use
Committee under the Animal Study Proposal (ASP) # NEI-597
approved on October 25, 2010).
Induction of EAU and Imaging Mouse Fundus
We induced EAU by active immunization with bovine
interphotoreceptor retinoid-binding protein (IRBP, 150 mg for
C57BL/6 mice, 50 mg for B10.A mice) and human IRBP peptide
(amino acid residues 1–20; 150 mg for C57BL/6 mice), in a 0.2 ml
emulsion (1:1) v/v with complete Freund’s adjuvant (CFA)
containing Mycobacterium tuberculosis strain H37Ra (2.5 mg/
ml). Mice also received Bordetella pertussis toxin (0.2 mg/mouse)
concurrent with immunization. Clinical disease was established
and scored by funduscopy as described [24,25]. Briefly, following
ip injection of ketamine (1.4 mg/mouse) and xylazine (0.12 mg/
mouse), pupils were dilated by topical administration of 1%
tropicamide ophthalmic solution (Alcon Inc, Fort Worth, Texas).
To avoid a subjective bias, evaluation of the fundus photographs
was conducted without knowledge of the mouse identity by
a masked observer. At least six images (2 posterior central retinal
view, 4 peripheral retinal views) were taken from each eye by
positioning the endoscope and viewing from superior, inferior,
lateral and medial fields and each individual lesion was identified,
mapped and recorded. The clinical grading system for retinal
inflammation was as previously established [26].
Isolation of Retinal Cells
Primary retinal cells were isolated as previously described [22].
Briefly, retinas were dissected out from enucleated eyes and briefly
rinsed in sterile PBS. Retinas were then diced in small pieces and
incubated in Hanks balanced salt solution (HBSS), containing
activated papain 120 U (Worthington, Lakewood NJ) and DNase
2000 U (Worthington), for 1 hour. To make single cell suspension
retinas were gently triturated with pipette and then passed through
a 40 mm cell strainer and centrifuged at 200 g for 5 min. The pellet
was resuspended in 1% ovalbumin (Worthington) in HBSS contain-
ing 500 UofDNase and layered on 5%ovalbumin solution inHBSS
and centrifuged for 10 min at 5006g. The pellet was resuspended in
medium [1:1] mixture of Dulbecco’s modified Eagle’s medium and
F12 medium containing 2.5% heat-inactivated horse serum, B27
medium supplement (Invitrogen, Carlsbad, CA), 5 mg/ml D-
glucose, 2 mM L-glutamine, 20 mM HEPES, 2.5 mg/ml bovine
insulin (Sigma, ST Louis, MO), and 0.1 mg/ml human transferrin
(Sigma; 15 000 cells/ml)]. Cell viability was consistently .90% as
assessed by Trypan blue exclusion and the Vi-CELL Cell Viability
Analyzer (Beckman Coulter).
Cell Culture and Interleukin 27 (IL-27) Treatment
The human RPE cell line (ARPE-19) was purchased from the
American Type Culture Collection (Manannas, VA). The ARPE-
19 cells were grown to confluence in minimum essential medium
(MEM) supplemented with 10% fetal bovine serum (FBS), 100 U/
ml penicillin, 100 mg/ml streptomycin, and 50 ng/ml amphoter-
icin B. The cells were washed twice in serum-free medium (SFM)
(HyClone, Logan, UT) and incubated in SFM containing human
recombinant IL-27 (10 ng/ml) (R&D) for varying amounts of time
at 37uC in 5% CO2. The protein synthesis inhibitor, cyclohex-
imide (CHX) (Sigma, St. Louis, MO), was used at 35 mg/ml and
added 30 minutes before addition of IL-27. Treatment with CHX
allows for discrimination between immediate effects of STAT1
and effects requiring de novo protein synthesis.
Small Interfering RNA (siRNA)–mediated Silencing of CFH
Expression
Cells were cultured to 60–70% confluence and transfected with
siRNA oligonucleotides (Santa Cruz). Cells were replated in six-
well plates and stimulated with IL-27 for varying amounts of time.
Complete knockdown of CFH occurred at 72 hour-time point and
was confirmed by RT-PCR analysis.
Western Blot Analysis
Whole cell lysates were prepared as previously described [27].
Briefly, extracts were fractionated on a 4–12% gradient SDS-
PAGE and proteins were then transferred to a PVDF membrane.
Antibodies used were: STAT1, pSTAT1, STAT3, pSTAT3 (Cell
signaling Technology), CFH, IRF-1, IRF-8, (Santa Cruz Bio-
technology). Pre-immune serum was used in parallel as controls
and signals were detected with HRP conjugated-secondary F(ab’)2
Abs (Zymed Labs, San Francisco, CA) using the ECL Plus Kit
(Amersham, Arlington Heights, IL).
Immunohistochemistry
Enucleated eyes were fixed in 4% paraformaldehyde and
embedded in Ameraffin tissue embedding medium (Baxter). Tissue
sections (5 mm) were deparaffinized in xylene, rehydrated through
a graded alcohol series. For detection of IRF-8, immunostaining
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was performed by the avidin-biotin-peroxidase complex method
(Vector Laboratories, Burlingame, CA.). Sections were pre-
incubation for 2 h with 5% blocking serum and then incubated
overnight at 4uC with antibodies (0.02 mg/ml) specific to mouse
IRF-8 (Santa Cruz). Control sections received the appropriate
normal serum. All sections were subsequently incubated with
biotinylated secondary antibody for 30 min at room temperature,
and signal was visualized with diaminobenzidine-H2O2 as
recommended (Vector). Sections were counterstained with hema-
toxylin. For detection of CFH expression, sections were blocked
with 5% normal goat serum and then incubated with CFH
antibody (Santa Cruz Biotechnology) overnight at 4uC. After
washing with ICC Buffer (PBS containing 0.5% BSA, 0.2%,
Tween 20 and 0.05% sodium Azide) sections were incubated with
donkey anti-goat Alexa-Fluor 488 and DAPI for 1 hr and
washed with ICC Buffer. Slides were mounted with Vectashield
Mounting medium for fluorescence (Vector Labs) and images
taken with a confocal microscope. Gain/offset settings were set at
the same level for all slides.
Quantitative and Semi-quantitative PCR Analyses
Total RNA was extracted from primary retinal cells or ARPE-
19 cells using the TriZol reagent according to the procedures
recommended by the manufacturer (Life Technologies, Gaithers-
burg, MD). All RNA samples were digested with RNase-free
DNase 1 (Life Technologies) for 30 min, purified by phenol/
chloroform extractions and precipitated in 0.4 M LiCl. RNA
(10 mg), SuperScript III Reverse Transcriptase (Life Technologies,
Gaithersburg, MD), and oligo (dT)12–18 were used for first-strand
synthesis as previously described [27]. Samples were subjected to
hot-start RT-PCR with gene-specific primers and AmpliTaq Gold
DNA polymerase (Applied Biosystems, Foster City, CA). First-
strand synthesis containing each mRNA sample but no reverse
transcriptase was performed to control for possible DNA
contamination of mRNAs used as target for PCR amplification;
failure to obtain RT-PCR products with any of the PCR
amplimers confirmed the absence of contaminating DNA
templates. PCR-amplified fragments were fractionated on agarose
gels. All cDNA preparations used were suitable substrates for PCR
amplification on the basis of efficient amplification of a ß-actin
sequence. Real-time PCR was performed on an ABI 7500 and
PCR parameters were as recommended for the TaqMan
Universal PCR kit (Applied Biosystems). Primers and probes were
purchased from Applied Biosystems).
Statistical Analysis
Statistical analyses were performed by independent two-tailed
Student’s t test. Probability values of #0.05 were considered
statistically significant.
Results
IL-27 Up-regulates the Expression of CFH in Retinal Cells
CFH expression has been detected in the retina, ciliary body,
sclera and the ocular lens [13]. To confirm these findings, we
performed immunohistochemical analysis of 8 weeks old C57BL/6
mouse eyes and the highest level of CFH expression was detected
in the RPE layer, photoreceptors, plexiform and ganglion cell
layers (Fig. 1A). We also confirmed the expression of CFH in the
retina of the C57BL/6 mouse by Western blot analysis. However
the level expressed by retinal cells was substantially lower than the
level detected in the liver (Fig. 1B). To investigate whether IL-27
induces CFH expression by the RPE, we cultured ARPE-19 cells
in medium containing IL-27 and RNA analysis of CFH expression
by quantitative PCR (qRT-PCR) revealed that ARPE-19 cells
constitutively expressed CFH and that IL-27 significantly up-
regulated the transcription of CFH (Fig. 1C) in a dose-dependent
manner (Fig. 1D). These results were confirmed at the protein
level by Western blotting analysis showing substantial induction of
CFH protein expression by IL-27 (Fig. 1E). We further show that
IL-27 induced the increase of CFH expression in ARPE-19
through activation of STAT1 and STAT3 pathways (Fig. 1F).
CFH Expression in the Mouse Retina Requires STAT1 and
is Up-regulated by IL-27
IL-27 induced the expression of CFH in ARPE-19 cells through
the activation of both STAT1 and STAT3 (Fig. 1E, 1F). It was
therefore of interest to determine whether both STAT1 and
STAT3 are required for IL-27-mediated increase of CFH by
analyzing CFH levels in retina of STAT1- or STAT3-deficient
mice. However, because STAT3 deficiency is embryonic lethal,
we used a Cre-loxP system to generate STAT3 conditional
knockout mice in which STAT3 gene was disrupted only in the
retina. Cre-recombinase expression was directed under control of
a retina-specific regulatory element of murine Pax6 (a-Cre) [23].
Western blot analysis of whole cell extracts of the retina-STAT3
knockout mouse strain (Ret-STAT32/2) indicates markedly
decreased STAT3 in the retina (Fig. 2A). To address the role of
STAT1 and/or STAT3 in IL-27-mediated induction of CFH, we
analyzed the expression of CFH in the retina of wild type C57BL/
6 (WT), STAT1-deficient (STAT12/2) [28] mice or mice with
targeted over-expression of SOCS1 in the retina under direction of
opsin promoter (SOCS1-Tg) [24]. Western blot analysis of whole
cell extracts prepared from freshly isolated retinal cells revealed
equivalent levels of CFH expression in the retinas of the WT and
STAT3-deficient mice (Fig. 2B), indicating that STAT3 expression
and/or activation is dispensable for the expression of CFH in the
retina. In contrast, we observed substantial decrease in CFH levels
in the retina of the STAT12/2 and SOCS1-Tg mice (Fig. 2B). It is
of note that the SOCS1-Tg mice are deficient in STAT1
activation [24], underscoring the requirement of STAT1 for
optimal expression of CFH in the normal retina. To confirm that
STAT1 is indeed required for IL-27-mediated induction of CFH
gene expression in the retina, we established retinal organ cultures
from freshly isolate retinas of WT or STAT1-deficient mice and
stimulated them overnight in medium containing IL-27. Results of
RT-PCR analysis of the RNA (Fig. 2C) or Western blot analysis of
whole cell extracts derived from the retinal cells (Fig. 2D) revealed
marked increase in CFH expression by WT retinal cells cultured in
medium containing IL-27. On the other hand, addition of IL-27 to
STAT1-deficient retina cultures could not induce the up-
regulation of CFH expression. Together, these results confirm
the requirement of STAT1 for IL-27-mediated induction of CFH
in the retina and underscore the physiological relevance of IL-27
in promoting the expression of CFH in the mammalian retina.
IRF-1 and IRF-8 Contribute to Transcriptional Activation
of CFH Gene in the Retina
Interferon Regulatory Factor (IRF) family of transcription
factors play important roles in gene-regulatory networks that
control cell growth, differentiation and host immunity [29]. IRF-1
and IRF-8 transcription factors are induced by IFN-g through
activation of STAT1 and in a previous study we showed that IFN-
g signaling in human RPE is mediated by STAT1, IRF-1 and
IRF-8 [30]. We therefore investigated whether the up-regulation
of CFH in the retina or ARPE-19 cells by IL-27 derived from
activation of IRF-1, IRF-8 and/or STAT1 genes. We starved
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ARPE-19 cells for 2 hours in SFM, treated the cells with IL-27 for
varying amounts of time (30 minutes to 24 hours) and examined
time-dependent effects of IL-27 on STAT1 activation and the
expression of CFH, IRF-1 or IRF-8. Western blot analysis
revealed that pSTAT1 was no longer detectable by the inception
of CFH expression (Fig. 3A), suggesting that the activation of
STAT1 pathway precedes CFH expression. On the other hand,
the kinetics of IL-27-mediated induction of CFH protein
expression correlated temporally with the expression IRF-1 and
IRF-8 expression (Fig. 3A). To further discern the roles of STAT1,
IRF-1 and IRF-8 in the induction of CFH expression, we blocked
de novo protein synthesis in some cultures by adding the protein
synthesis inhibitor, cycloheximide (CHX). This allowed discrim-
ination between the immediate effects of STAT1 activation on
CFH expression from secondary effects deriving from STAT1-
induced expression of IRF-1 and IRF-8. The stimulation of the
ARPE-19 cells with IL-27 induced robust activation of STAT1
and STAT3 pathways (pSTAT1 and pSTAT3) and was un-
affected by the blockade of protein synthesis (Fig. 3B). Western
blot analysis also revealed that the induction of CFH expression by
IL-27 correlated temporally with the expression of IRF-1 and IRF-
8 (Fig. 3C). However, blocking protein synthesis with CHX
abrogated the expression of IRF-1 and significantly reduced IL-27
induction of CFH expression but had no effect on IRF-8 level
(Fig. 3C). qPCR analysis revealed significant suppression of CFH
mRNA transcription by cells treated with CHX despite robust
STAT1 activation, indicating that de novo synthesis of IRF-1 may
be required for optimal expression of CFH (Fig. 3D). Interestingly,
the expression of CFH RNA in the CHX treated cells was still
higher than untreated cells (Fig. 3D), suggesting that this increase
in CFH mRNA derived from the IRF-8 still present in these cells
(see Fig. 3C). To directly investigate the role of IRF-1 and IRF-8 in
IL-27-mediated induction of CFH protein expression, we stimu-
lated ARPE-19 cells with IL-27 for varying amounts of time in the
presence or absence of control siRNA, IRF-1 siRNA or IRF-8
siRNA. Complete knockdown of IRF-1 or IRF-8 was observed at
72 hours and confirmed by RT-PCR analysis (data not shown). As
shown siRNA-mediated knockdown of IRF-1 or IRF-8 abrogated
CFH protein expression, indicating the involvement of IRF-1 and
IRF-8 in CFH expression in ARPE-19 cells (Fig. 4).
Figure 1. CFH is constitutively expressed in the retina and up-regulated in RPE cells by IL-27 through STAT1-dependent
mechanism. (A) Immunohistochemical localization of CFH expression in the mouse retina. Retina pigmented epithelium (RPE); Photoreceptors
(pho); outer nuclear layer (ONL); outer plexiform layer (OPL); inner plexiform layer (IPL). (B) Whole cell extracts prepared from the retina or liver of
C57BL/6 mice were analyzed for expression of CFH by Western blot assay. (C) ARPE-19 cells were stimulated for 24 hours in medium containing
human IL-27 (10 ng/ml). ARPE-19 cells were cultured overnight in complete medium, washed and starved in serum free medium (SFM) for 2 hours
and then stimulated in SFM containing human recombinant IL-27 (10 ng/ml) for 24 hours (C, D, E) or 30 minutes (F). (C) RNA was isolated and
analyzed by qRT-PCR. (D) The ARPE-19 cells were stimulated with several concentrations of human IL-27 and then subjected to qRT-PCR analysis. (E, F)
Whole cell extracts were analyzed by Western blot assay.
doi:10.1371/journal.pone.0045801.g001
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Figure 2. IL-27 induces CFH expression in the retina through STAT1-dependent mechanism. (A) Characterization of retina from mice with
specific deletion of STAT3 in the retina (Ret-STAT32/2). (B) Freshly isolated retinas from wild type (WT), STAT1 knockout (STAT12/2), (Ret-STAT32/2),
or from mice with targeted over-expression of SOCS1 in the retina (SOCS1Tg) were analyzed by RT-PCR. (C, D) Freshly isolated retinal cells from WT or
STAT12/2 mice were cultured overnight, washed, starved for 2 hours in serum-free medium and then cultured for an additional 22 hours in medium
containing IL-27 (10 ng/ml). We analyzed RNA and total cell extracts from the cells by RT-PCR (C) or Western blotting (D).
doi:10.1371/journal.pone.0045801.g002
Figure 3. IL-27 induces expression of CFH through STAT1-mediated up-regulation of IRF-1 and IRF-8. (A–C) ARPE-19 cells were starved
for 2 hours in serum free medium and cultures were then stimulated with IL-27 (10 ng/ml) for 30, 90 or 720 min. (B–D) In other cultures, cells were
treated with CHX (35 ug/ml) for 30 min prior treatment with IL-27 for 30 min (B) or 24 h (C, D). Whole cell extracts were analyzed by Western blot
assay and the antibodies used are indicated. (D) CFH mRNA transcripts were detected and quantified by qRT-PCR.
doi:10.1371/journal.pone.0045801.g003
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IRF-8/IRF-1 are Constitutively Expressed in Retina and Up-
regulated during Ocular Inflammation
Data presented thus far suggest the involvement of IRF-1 and
IRF-8 in the regulation of CFH expression in ARPE-19 cells. It
was therefore of interest to investigate whether IRF-1 and IRF-8
are expressed in the mouse retina and if their levels increase during
intraocular inflammation. We addressed these points in experi-
mental autoimmune uveitis (EAU), a mouse model of intraocular
inflammation or uveitis [31,32]. We induced EAU in C57BL/6
mice by immunization with the retinal autoantigen, interphotor-
eceptor retinoid binding protein (IRBP) [32,33]. Fundus photo-
graphs showing papillitis (black arrow), retinal vasculitis (red
diamond) with cuffing (blue arrows) and brownish/whitish retinal
and choroidal infiltrates (white arrows) taken at day-21 post-
immunization confirmed the development of EAU (Fig. 5). Retina
was isolated from un-immunized or IRBP-immunized mice and
RNA analysis by qRT-PCR indicates that the increase in CFH
expression in the retina during inflammation (Fig. 5B) was
accompanied by a corresponding increase in the transcription of
genes coding for IRF-1, IRF-8 and IL-27 (IL27p28 and EBI3)
(Fig. 5C).
Detection of IRF-8 Protein in the Retina in the Ganglion
and Inner Nuclear Layers of the Retina
In contrast to other members of the IRF family, IRF-8
expression has been detected mainly in myeloid cells and cells in
the ocular lens [29,34]. Although IRF-1 and IRF-8 mRNA
transcripts were detected in the normal retina and up-regulated
during EAU (Fig. 5C), it was important to demonstrate that the
proteins were also present in the retina. Consistent with our RNA
data, Western blot analysis revealed that IRF-1 and IRF-8
proteins are constitutively expressed in the normal mouse retina
and their levels increased dramatically during EAU (Fig. 6A, 6B).
Because cells of the myeloid/hematopoietic lineage such as
microglia are resident cells of the mammalian retina [22,35,36],
we examined whether these cells are the source of IRF-8 detected
in the retina. Immunohistochememical analysis of paraffin-mixed
sections using IRF-8-specific Abs detected intense immuno-
reactivity within the ganglion cell layer of normal mouse retina
(Fig. 6C). Consistent with increase of IRF-8 mRNA and protein in
the retina during EAU, we observed marked elevation of the level
of IRF-8 in ganglion and outer nuclear layers of mice with EAU
(Fig. 6; right panel). Unfortunately, similar analysis using IRF-1
Abs from several commercial sources gave un-reproducible results.
Discussion
The complement system is a critical component of innate
immunity in the eye and CFH is constitutively expressed by retinal
cells to protect terminally differentiated photoreceptors and retinal
neurons from prolonged or inappropriate activation of the
complement system in the neuroretina. Although recent studies
using the ARPE-19 cell line suggest that IFN-g regulates CFH
expression in RPE cells through activation of STAT1 [12,19],
factors that activate the STAT1 required for CFH transcription in
the retina are unknown since retinal cells do not produce the pro-
inflammatory cytokine, IFN-g.
In this study, we have shown that STAT1-deficient mice express
much lower level of CFH in the retina compared to WT mice
(Fig. 2B), suggesting that STAT1 is not only essential for activation
of the transcription of CFH gene in ARPE-19 cells but also by
resident cells of the mammalian retina. We further show that the
anti-inflammatory cytokine, IL-27, induces the expression of CFH
in retina (Fig. 2C, 2D) and ARPE-19 cells (Fig. 1C, 1D, 1E) in
a dose dependent manner. Whereas IL-27 induced CFH in WT
retinal cells, it could not up-regulate CFH expression in STAT1-
deficient retinal cells indicating a requirement of STAT1-de-
pendent mechanisms. In this context, it is interesting that STAT1
directly interacts with the IL-27p28 promoter and induces
production of IL-27 by RPE cells, indicating the central role of
STAT1 in regulating CFH and IL-27 [21,22]. The requirement of
STAT1 for expression of CFH and IL-27 suggests that production
of the two proteins in the retina may be linked or coordinately
regulated. The physiological relevance of IL-27 in the retina and
RPE is further underscored by recent reports showing that the
RPE, photoreceptors and retinal ganglion cells expression IL-27 as
well as IL-27 receptors [21,22]. It is particularly intriguing that the
RPE and these layers of the retina express high levels of CFH [13].
Taken together, the constitutive production of IL-27 in the retina,
its signaling through STAT1 and its up-regulation of CFH in
ARPE-19 and mouse retinal cells, make a compelling case that IL-
27 may play important roles as a physiological inducer of CFH in
the mouse retina.
Figure 4. siRNA-mediated silencing of IRF-1 or IRF-8 abrogated the induction of CFH by IL-27. ARPE-19 cells were stimulated with human
IL-27 in the presence or absence of control siRNA, IRF-1 siRNA or IRF-8 siRNA. (A) Detection of CFH expression by Western blot analysis. (B) Blots were
analyzed and relative levels of CFH protein were quantified by densitometry; samples were normalized to the GAPDH expression level.
doi:10.1371/journal.pone.0045801.g004
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Figure 5. Expression of IRF-1, IRF-8 and IL-27 (IL27p28/EBi3) by retinal cells was up-regulated during experimental autoimmune
uveitis (EAU). (A) Fundus images of the retina of un-immunized mouse and mouse with EAU. (B, C) Retinas were isolated from control or EAU mice
and analyzed for IRF-1, IRF-8, CFH, IL27p28 or EBi3 expression by qRT-PCR.
doi:10.1371/journal.pone.0045801.g005
Figure 6. Detection and localization of IRF-1 and IRF-8 proteins in the retina. Retinas were isolated from control or EAU mice and whole cell
extracts were analyzed for IRF-1 (A) or IRF-8 expression by Western blot analysis. (C) Immunohistochemical localization of IRF-8 expression was
detected in the normal mouse retina or retina of mice with EAU using an IRF-8-specific antibody as described in Methods section. Retina pigmented
epithelium (RPE); Photoreceptors (pho); outer nuclear layer (ONL); outer plexiform layer (OPL); inner plexiform layer (IPL).
doi:10.1371/journal.pone.0045801.g006
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Blocking protein synthesis with CHX did not inhibit STAT1
activation but abrogated the IL-27-induced expression of CFH
(Fig. 3C), suggesting that de novo protein synthesis is required for
IL-27-mediated increase in CFH expression. Although previous
studies have emphasized the role of STAT1 in CFH expression,
our results suggest that while STAT1 is clearly required for
optimal expression of CFH (Fig. 2), its role may merely be to
induce expression of additional transcriptional factors that may be
the direct inducers of CFH transcription. We have shown that the
induction of CFH expression by IL-27 was dose dependent and
temporally correlated with the expression of IRF-1 and IRF-8
(Fig. 3A, 3C). In addition, both IRF-1 and IRF-8 are expressed in
ARPE-19 cells and mouse retina, suggesting that they may play
a role in maintaining physiological levels of CFH in the retina.
IRF-1 is the best characterized of the 10-member IRF family and
is thought to regulate immunological responses [29,37,38].
Constitutive expression of IRF-1 by resident retinal cells is not
particularly surprising in view of the fact that IRF-1 is ubiquitously
expressed in many tissues and cell types. On the other hand, with
the exception of the ocular lens [34,39], the expression of IRF-8
has thus far been detected in cells of hematopoietic lineage
[40,41,42]. During EAU, expression of IRF-8 and IRF-1 was
dramatically increased (Fig. 6A, 6B) and we show that IRF-8 is
marked elevated in ganglion and outer nuclear layers (Fig. 6C).
Nonetheless, while our data indicate that IL-27 induces expression
of IRF-1 and IRF-8 in the retina, a recent report indicates that IL-
27p28 expression is decreased in IRF-8 knockout mice [43].
Moreover, over-expression of both IRF-8 and IRF-1 cooperatively
activated IL-27p28 promoter [43], suggesting a positive regulatory
mechanism for increasing IL-27, IRF-1 and IRF-8. It is therefore
tempting to speculate that existence of such a feed-forward loop
would undoubtedly contribute to mechanisms that sustain
requisite levels of CFH in the retina.
In summary, the data presented describe the role of three
transcription factors (STAT1, IRF-1, IRF-8) that converge to
induce and/or enhance the expression of CFH in the retina and
we have shown that they are all induced by the anti-inflammatory
cytokine, IL-27. We further show that while STAT1 is required for
optimal expression of CFH, its role appears to be for inducing
IRF-1 and IRF-8 or other transcription factors that enhance the
expression of CFH in RPE and retina. While the temporal
patterns of expression suggest that IRF-1 and IRF-8 may be
required for increasing CFH expression in response to IL-27
signaling, the constitutive expression of IRF-8 and IL-27 in the
retina is consistent with their involvement in expression of CFH in
the retina under normal physiological condition. Collectively, our
data showing that IL-27 induced expression of CFH by retinal
cells extends its anti-inflammatory functions in the retina and
suggest that IL-27 might contribute to mechanisms of ocular
immune-privilege by mitigating deleterious effects of complement
proteins in retina during inflammation through activation of
STAT1 and up-regulation of IRF-1 and IRF-8. Thus, it is
conceivable that defects in IL-27 signaling or regulation of IRF-1/
IRF-8 expression may contribute to the reduced amounts of CFH
observed in retina of patients with AMD.
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